tetano
Editor, Senior Moderator
One year ago, the first wave of the virus A (H1N1) had just hit. In Quebec, 25 persons had died. Experts of everywhere in the world met in Winnipeg to take stock of the situation. The Agency of public health of Canada announced that all population would have access to a vaccine. They waited for the second wave of the pandemic. Today, the pandemic is behind us, but the virus continues circulating. It acts as a virus of seasonal influenza. Consequently, it will be inserted into the next vaccine. It will be necessary to be made there: the virus A (H1N1) became established among us. To such an extent that seasonal vaccine against influenza will give a double protection now. Besides containing the classical stocks of type A and B, it will contain a stump to immunize the population against the virus A (H1N1). In Quebec, vaccine will be available from November 1st. And it will not be necessary to stand in a queue in a centre of vaccination to acquire it.
Other novelty this year, taught The Press, the Ministry of Health, in accordance with the recommendation of the committee of experts in immunization of the province, will give vaccine free to two new groups judged at risk?: the persons suffering from morbid obesity the indication of bodily mass (IMC) of which is 40 and more, and the pregnant wives in good health whose pregnancy belongs to the second or there in the third quarter. Elsewhere in the country, several provinces decided to give vaccine free to all population. After analysis, Quebec nevertheless decided to make loner by thinking that the adults in good health have a rather strong immune system to fight the virus.
For the first time, seasonal vaccine was moreover the object of clinical pancanadiens tries before being approved, said the Dr Mark Dionne, scientific manager (biological risks and health at job) in the national Institute of public health of Quebec (INSPQ). These clinical tries allowed to predict with more effectiveness side effects of vaccine. They already know that main inconvenience will be pain (50 % of cases or more) in the site of injection.
Vaccine could also draw away wrong of head, feeling of tiredness and articular pain.
The pain in the arm should nevertheless be lesser than last year since doses, with which 75 % will provided by the giant GlaxoSmithKline (GSK), will not contain an adjuvant.
? In mid-August, 350 persons were vaccinated in week, explains the Dr Dionne. Some people accepted a placebo, others vaccine, and the opposite two weeks later. They made daily catches of blood to watch side effects. It was two years since they attracted these clinical tries, but unsuccessfully. They are going to make it now every year. ?
...
http://www.cyberpresse.ca/dossiers/...1865-pas-de-vaccination-a-grande-echelle-.php
Other novelty this year, taught The Press, the Ministry of Health, in accordance with the recommendation of the committee of experts in immunization of the province, will give vaccine free to two new groups judged at risk?: the persons suffering from morbid obesity the indication of bodily mass (IMC) of which is 40 and more, and the pregnant wives in good health whose pregnancy belongs to the second or there in the third quarter. Elsewhere in the country, several provinces decided to give vaccine free to all population. After analysis, Quebec nevertheless decided to make loner by thinking that the adults in good health have a rather strong immune system to fight the virus.
For the first time, seasonal vaccine was moreover the object of clinical pancanadiens tries before being approved, said the Dr Mark Dionne, scientific manager (biological risks and health at job) in the national Institute of public health of Quebec (INSPQ). These clinical tries allowed to predict with more effectiveness side effects of vaccine. They already know that main inconvenience will be pain (50 % of cases or more) in the site of injection.
Vaccine could also draw away wrong of head, feeling of tiredness and articular pain.
The pain in the arm should nevertheless be lesser than last year since doses, with which 75 % will provided by the giant GlaxoSmithKline (GSK), will not contain an adjuvant.
? In mid-August, 350 persons were vaccinated in week, explains the Dr Dionne. Some people accepted a placebo, others vaccine, and the opposite two weeks later. They made daily catches of blood to watch side effects. It was two years since they attracted these clinical tries, but unsuccessfully. They are going to make it now every year. ?
...
http://www.cyberpresse.ca/dossiers/...1865-pas-de-vaccination-a-grande-echelle-.php